OverviewSuggest Edit

MRI Interventions is a medical device company. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging guidance. The company offers ClearPoint system, a neuro intervention system that is used to perform minimally invasive surgical procedures in the brain. It is also developing ClearTrace system, a cardiac intervention system for performing minimally invasive surgical procedures in the heart.

TypePublic
Founded1998
HQIrvine, US
Websitemriinterventions.com

Latest Updates

Employees (est.) (Mar 2019)38(+12%)
Revenue (FY, 2019)$11.2 M(+53%)
Share Price (Mar 2020)$3.4 (-1%)

Key People/Management at MRI Interventions

Joseph M. Burnett

Joseph M. Burnett

Chief Executive Officer
Peter G. Piferi

Peter G. Piferi

Chief Operating Officer
Harold A. Hurwitz

Harold A. Hurwitz

Chief Financial Officer
Chris Yelley

Chris Yelley

Vice President, Operations
Jacqueline Keller

Jacqueline Keller

Vice President, Marketing
Show more

MRI Interventions Office Locations

MRI Interventions has an office in Irvine
Irvine, US (HQ)
5 Musick
Show all (1)

MRI Interventions Financials and Metrics

MRI Interventions Revenue

Embed Graph
View revenue for all periods
MRI Interventions's revenue was reported to be $11.22 m in FY, 2019
USD

Revenue (FY, 2019)

11.2m

Gross profit (FY, 2019)

7.4m

Gross profit margin (FY, 2019), %

65.8%

Net income (FY, 2019)

(5.5m)

EBIT (FY, 2019)

(4.6m)

Market capitalization (25-Mar-2020)

80.5m

Closing stock price (25-Mar-2020)

3.4

Cash (31-Dec-2019)

5.7m

EV

77.2m
MRI Interventions's current market capitalization is $80.5 m.
Annual
USDFY, 2016FY, 2017FY, 2018FY, 2019

Revenue

5.7m7.4m7.4m11.2m

Revenue growth, %

25%28%0%

Cost of goods sold

2.6m2.9m2.4m3.8m

Gross profit

3.1m4.5m4.9m7.4m
Quarterly
USDQ1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019

Revenue

2.0m2.0m1.7m1.6m1.6m1.8m2.5m2.6m2.9m

Cost of goods sold

752.5k798.5k688.8k589.0k602.2k553.2k886.5k1.0m983.0k

Gross profit

1.3m1.2m1.0m1.0m1.0m1.3m1.6m1.6m1.9m

Gross profit Margin, %

63%60%60%64%63%69%64%60%66%
Annual
USDFY, 2016FY, 2017FY, 2018FY, 2019

Cash

3.3m9.3m3.1m5.7m

Accounts Receivable

865.9k949.4k1.2m1.1m

Prepaid Expenses

135.0k192.7k213.7k357.2k

Inventories

1.8m2.3m2.1m3.2m
Quarterly
USDQ1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019

Cash

2.0m12.7m11.0m7.5m6.7m3.7m2.5m7.5m6.2m

Accounts Receivable

1.0m750.8k863.8k910.1k770.8k1.1m1.3m1.4m2.1m

Prepaid Expenses

95.6k270.5k239.3k153.2k321.6k261.9k199.6k430.6k364.3k

Inventories

1.8m1.9m2.2m2.5m2.7m2.5m2.0m2.5m3.2m
Annual
USDFY, 2016FY, 2017FY, 2018FY, 2019

Net Income

(8.1m)(7.2m)(6.2m)(5.5m)

Depreciation and Amortization

155.7k116.5k109.4k250.6k

Inventories

72.3k(469.9k)122.2k(1.0m)

Accounts Payable

178.4k(512.4k)(284.3k)1.2m
USDY, 2019

EV/EBIT

-16.8 x

EV/CFO

-27.1 x

Revenue/Employee

295.2k

Financial Leverage

2.6 x
Show all financial metrics

MRI Interventions Operating Metrics

Nov, 2019

Industry Partners

3

Patent Applications

95

Patents Issued

95
Show all operating metrics

MRI Interventions Acquisitions / Subsidiaries

Company NameDateDeal Size
MRI Interventions (Canada) Inc.

MRI Interventions Revenue Breakdown

Embed Graph

MRI Interventions revenue breakdown by business segment: 9.1% from Service and Other and 90.9% from Product

MRI Interventions Online and Social Media Presence

Embed Graph

MRI Interventions News and Updates

MRI Interventions, Inc. Announces Uplisting to NYSE American

Stock Will Trade Under Its Existing Symbol ‘MRIC’ Starting July 3, 2019 Stock Will Trade Under Its Existing Symbol ‘MRIC’ Starting July 3, 2019

MRI Interventions Announces Closing of $7.522 Million Private Placement

IRVINE, Calif., May 17, 2019 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB: MRIC) today announced the closing on May 17, 2019 of its previously disclosed private placement of shares of common stock, which resulted in gross proceeds of $7.522 million. The 2,426,455 shares of MRI Interventions’…

MRI Interventions Reports 36% Increase in Fourth Quarter Revenue and Record Quarterly ClearPoint® Cases

Fourth Quarter Cash Burn from Operations Reduced to $600,000 Fourth Quarter Cash Burn from Operations Reduced to $600,000

MRI Interventions, Inc. to Announce Fourth Quarter and Full Year 2018 Results on March 11

IRVINE, Calif., March 06, 2019 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB:MRIC), a platform neurosurgery company with products designed to deliver navigation, ablation, deep brain stimulation, biopsy and gene therapy, today announced that it will release financial results for its 2018 four…

MRI Interventions to Host Meetings at Roth Capital Conference on March 18

IRVINE, Calif., March 01, 2019 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB:MRIC), a platform neurosurgery company with products designed for navigation in procedures for deep brain stimulation, ablation, aspiration and gene therapy, today announced that Joe Burnett, CEO, will host investor …

MRI Interventions Congratulates Voyager Therapeutics on First Patient Dosing in RESTORE-1, the Phase 2 VY-AADC Gene Therapy Trial for Parkinson’s Disease

IRVINE, Calif. , Dec. 10, 2018 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB:MRIC), a platform neurosurgery company with products designed for navigation, ablation and gene therapy, today announced participation in the RESTORE-1 gene therapy trial for Parkinson’s disease sponsored by Voyager …
Show more

MRI Interventions Blogs

ClearPoint Neuro Reports 53% Increase in 2019 Revenue

Fourth quarter revenue grows 41%, fifth consecutive quarter of revenue growth  IRVINE, Calif., Feb. 12, 2020 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (formerly, MRI Interventions, Inc.; the “Company”) today announced financial results for its fourth fiscal quarter and full year e…

ClearPoint Neuro to Announce Fourth Quarter and Full Year 2019 Results February 12

Release and Call After Market Close IRVINE, Calif., Feb. 11, 2020 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (formerly, MRI Interventions, Inc.; the “Company”, formerly Nasdaq: MRIC) today announced that it will release financial results for its 2019 fourth quarter and full year, w…

MRI Interventions, Inc. Changes Corporate Name to ClearPoint Neuro, Inc.

Company To Commence Trading Under Ticker Symbol CLPT on February 12, 2020 IRVINE, Calif., Feb. 11, 2020 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (Nasdaq: MRIC) (the “Company”), a leading platform neurosurgery company, will effectuate its previously announced change of its corporate name to Cle…

MRI Interventions, Inc. Closes $17.5 Million Strategic Investment from PTC Therapeutics, Inc. and Petrichor Healthcare Capital Management

IRVINE, Calif., Jan. 29, 2020 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (Nasdaq: MRIC) (the “Company”), a leading platform neurosurgery company, closed its previously announced $17.5 million strategic investment from PTC Therapeutics, Inc. (“PTC”) and Petrichor Healthcare Capital Management (“Pe…

MRI Interventions, Inc. Obtains a $17.5 Million Strategic Investment from PTC Therapeutics, Inc. and Petrichor Healthcare Capital Management

Transaction follows 43% growth in fourth quarter revenue IRVINE, Calif., Jan. 13, 2020 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (Nasdaq: MRIC) (the “Company”), a leading platform neurosurgery company, today announced preliminary and unaudited results for the quarter ended December 31, 2019. Ad…

MRI Interventions, Inc. To Change Corporate Name to ClearPoint Neuro, Inc.

Company to Trade Under New Name and Ticker Symbol on February 14, 2020 IRVINE, Calif., Jan. 13, 2020 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (Nasdaq: MRIC) (the “Company”), a leading platform neurosurgery company, today announced plans to change its corporate name to ClearPoint Neuro, Inc. As…
Show more

MRI Interventions Frequently Asked Questions

  • When was MRI Interventions founded?

    MRI Interventions was founded in 1998.

  • Who are MRI Interventions key executives?

    MRI Interventions's key executives are Joseph M. Burnett, Peter G. Piferi and Harold A. Hurwitz.

  • How many employees does MRI Interventions have?

    MRI Interventions has 38 employees.

  • What is MRI Interventions revenue?

    Latest MRI Interventions annual revenue is $11.2 m.

  • What is MRI Interventions revenue per employee?

    Latest MRI Interventions revenue per employee is $295.2 k.

  • Who are MRI Interventions competitors?

    Competitors of MRI Interventions include Livanova, Safe Orthopaedics and SeaSpine.

  • Where is MRI Interventions headquarters?

    MRI Interventions headquarters is located at 5 Musick, Irvine.

  • Where are MRI Interventions offices?

    MRI Interventions has an office in Irvine.

  • How many offices does MRI Interventions have?

    MRI Interventions has 1 office.